vs
ASP Isotopes Inc.（ASPI）与Monte Rosa Therapeutics, Inc.（GLUE）财务数据对比。点击上方公司名可切换其他公司
ASP Isotopes Inc.的季度营收约是Monte Rosa Therapeutics, Inc.的1.3倍（$16.7M vs $12.8M），ASP Isotopes Inc.同比增速更快（1295.7% vs 38.5%），Monte Rosa Therapeutics, Inc.自由现金流更多（$99.8M vs $-47.4M）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
Monte Rosa Therapeutics是一家临床阶段生物技术企业，专注于研发靶向分子胶降解剂疗法，管线覆盖肿瘤、罕见遗传病及免疫疾病领域的未满足医疗需求，通过自主研发与行业合作推进创新疗法惠及全球患者。
ASPI vs GLUE — 直观对比
营收规模更大
ASPI
是对方的1.3倍
$12.8M
营收增速更快
ASPI
高出1257.1%
38.5%
自由现金流更多
GLUE
多$147.2M
$-47.4M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $12.8M |
| 净利润 | — | $-27.1M |
| 毛利率 | 12.5% | — |
| 营业利润率 | — | -258.3% |
| 净利率 | — | -212.1% |
| 营收同比 | 1295.7% | 38.5% |
| 净利润同比 | -586.8% | -13.5% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPIGLUE
| Q4 25 | $16.7M | — | ||
| Q3 25 | $4.9M | $12.8M | ||
| Q2 25 | — | $23.2M | ||
| Q1 25 | — | $84.9M | ||
| Q4 24 | — | $60.6M | ||
| Q4 23 | — | $0 | ||
| Q3 23 | — | $0 | ||
| Q2 23 | — | $0 |
净利润ASPIGLUE
| Q4 25 | — | — | ||
| Q3 25 | $-12.9M | $-27.1M | ||
| Q2 25 | — | $-12.3M | ||
| Q1 25 | — | $46.9M | ||
| Q4 24 | — | $13.4M | ||
| Q4 23 | — | $-33.3M | ||
| Q3 23 | — | $-34.9M | ||
| Q2 23 | — | $-35.2M |
毛利率ASPIGLUE
| Q4 25 | 12.5% | — | ||
| Q3 25 | 8.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
营业利润率ASPIGLUE
| Q4 25 | — | — | ||
| Q3 25 | -306.1% | -258.3% | ||
| Q2 25 | — | -67.1% | ||
| Q1 25 | — | 51.9% | ||
| Q4 24 | — | 21.4% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
净利率ASPIGLUE
| Q4 25 | — | — | ||
| Q3 25 | -263.7% | -212.1% | ||
| Q2 25 | — | -53.0% | ||
| Q1 25 | — | 55.2% | ||
| Q4 24 | — | 22.2% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
每股收益（稀释后）ASPIGLUE
| Q4 25 | — | — | ||
| Q3 25 | $-0.15 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $208.3M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $245.8M |
| 总资产 | $498.0M | $459.8M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPIGLUE
| Q4 25 | $333.3M | — | ||
| Q3 25 | $113.9M | $208.3M | ||
| Q2 25 | — | $69.4M | ||
| Q1 25 | — | $78.5M | ||
| Q4 24 | — | $224.3M | ||
| Q4 23 | — | $128.1M | ||
| Q3 23 | — | $59.1M | ||
| Q2 23 | — | $47.0M |
总债务ASPIGLUE
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
股东权益ASPIGLUE
| Q4 25 | $204.2M | — | ||
| Q3 25 | $74.1M | $245.8M | ||
| Q2 25 | — | $268.1M | ||
| Q1 25 | — | $275.2M | ||
| Q4 24 | — | $222.9M | ||
| Q4 23 | — | $179.3M | ||
| Q3 23 | — | $184.5M | ||
| Q2 23 | — | $213.7M |
总资产ASPIGLUE
| Q4 25 | $498.0M | — | ||
| Q3 25 | $225.9M | $459.8M | ||
| Q2 25 | — | $359.6M | ||
| Q1 25 | — | $393.2M | ||
| Q4 24 | — | $438.7M | ||
| Q4 23 | — | $303.8M | ||
| Q3 23 | — | $252.1M | ||
| Q2 23 | — | $278.6M |
负债/权益比ASPIGLUE
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | $100.4M |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | $99.8M |
| 自由现金流率自由现金流/营收 | -284.7% | 781.5% |
| 资本支出强度资本支出/营收 | 57.9% | 5.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $145.0M |
8季度趋势，按日历期对齐
经营现金流ASPIGLUE
| Q4 25 | $-37.8M | — | ||
| Q3 25 | $-8.9M | $100.4M | ||
| Q2 25 | — | $-34.7M | ||
| Q1 25 | — | $-45.5M | ||
| Q4 24 | — | $128.9M | ||
| Q4 23 | — | $29.6M | ||
| Q3 23 | — | $-24.7M | ||
| Q2 23 | — | $-25.3M |
自由现金流ASPIGLUE
| Q4 25 | $-47.4M | — | ||
| Q3 25 | $-12.0M | $99.8M | ||
| Q2 25 | — | $-36.4M | ||
| Q1 25 | — | $-47.1M | ||
| Q4 24 | — | $128.7M | ||
| Q4 23 | — | $27.9M | ||
| Q3 23 | — | $-26.4M | ||
| Q2 23 | — | $-31.8M |
自由现金流率ASPIGLUE
| Q4 25 | -284.7% | — | ||
| Q3 25 | -245.5% | 781.5% | ||
| Q2 25 | — | -157.0% | ||
| Q1 25 | — | -55.4% | ||
| Q4 24 | — | 212.3% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资本支出强度ASPIGLUE
| Q4 25 | 57.9% | — | ||
| Q3 25 | 64.4% | 5.1% | ||
| Q2 25 | — | 7.3% | ||
| Q1 25 | — | 1.9% | ||
| Q4 24 | — | 0.3% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
现金转化率ASPIGLUE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.97× | ||
| Q4 24 | — | 9.59× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
